Chesi M - Search Results

1

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.

López-Iglesias AA, Herrero AB, Chesi M, San-Segundo L, González-Méndez L, Hernández-García S, Misiewicz-Krzeminska I, Quwaider D, Martín-Sánchez M, Primo D, Paíno T, Bergsagel PL, Mehrling T, González-Díaz M, San-Miguel JF, Mateos MV, Gutiérrez NC, Garayoa M, Ocio EM. López-Iglesias AA, et al. Among authors: chesi m. J Hematol Oncol. 2017 Jun 20;10(1):127. doi: 10.1186/s13045-017-0495-y. J Hematol Oncol. 2017. PMID: 28633670 Free PMC article.

2

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Chesi M, et al. Blood. 1996 Jul 15;88(2):674-81. Blood. 1996. PMID: 8695815 Free article.

3

Selective expression of one c-myc allele in two human myeloma cell lines.

Kuehl WM, Brents LA, Chesi M, Bergsagel PL. Kuehl WM, et al. Among authors: chesi m. Cancer Res. 1996 Oct 1;56(19):4370-3. Cancer Res. 1996. PMID: 8813127

4

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.

Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL. Chesi M, et al. Nat Genet. 1997 Jul;16(3):260-4. doi: 10.1038/ng0797-260. Nat Genet. 1997. PMID: 9207791 Free PMC article.

5

Dysregulation of c-myc in multiple myeloma.

Kuehl WM, Brents LA, Chesi M, Huppi K, Bergsagel PL. Kuehl WM, et al. Among authors: chesi m. Curr Top Microbiol Immunol. 1997;224:277-82. doi: 10.1007/978-3-642-60801-8_29. Curr Top Microbiol Immunol. 1997. PMID: 9308252

6

IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.

Bergsagel PL, Nardini E, Brents L, Chesi M, Kuehl WM. Bergsagel PL, et al. Among authors: chesi m. Curr Top Microbiol Immunol. 1997;224:283-7. doi: 10.1007/978-3-642-60801-8_30. Curr Top Microbiol Immunol. 1997. PMID: 9308253

7

Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.

Gabrea A, Bergsagel PL, Chesi M, Shou Y, Kuehl WM. Gabrea A, et al. Among authors: chesi m. Mol Cell. 1999 Jan;3(1):119-23. doi: 10.1016/s1097-2765(00)80180-x. Mol Cell. 1999. PMID: 10024885 Free article.

8

Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.

Chesi M, Kuehl WM, Bergsagel PL. Chesi M, et al. Ann Oncol. 2000;11 Suppl 1:131-5. Ann Oncol. 2000. PMID: 10707795 Review.

9

The enigma of ectopic expression of FGFR3 in multiple myeloma: a critical initiating event or just a target for mutational activation during tumor progression.

Chesi M, Bergsagel PL, Kuehl WM. Chesi M, et al. Curr Opin Hematol. 2002 Jul;9(4):288-93. doi: 10.1097/00062752-200207000-00005. Curr Opin Hematol. 2002. PMID: 12042702 Review.

10

Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma.

Trudel S, Ely S, Farooqi Y, Affer M, Robbiani DF, Chesi M, Bergsagel PL. Trudel S, et al. Among authors: chesi m. Blood. 2004 May 1;103(9):3521-8. doi: 10.1182/blood-2003-10-3650. Epub 2004 Jan 8. Blood. 2004. PMID: 14715624 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page